Holdings
Rosalind Advisors, Inc.
As of Jun 30, 2026, Rosalind Advisors, Inc. reported 26 positions worth US$251M. Largest: Delcath Systems, Inc., Fennec Pharmaceuticals Inc. and Xeris Biopharma Holdings, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Delcath Systems, Inc. | 3.3M | US$41.6M | no change | Jun 30, 2026 |
| Fennec Pharmaceuticals Inc. | 3.19M | US$34.3M | +280K | Jun 30, 2026 |
| Xeris Biopharma Holdings, Inc. | 2.91M | US$23M | −323K | Jun 30, 2026 |
| Savara, Inc. | 3.18M | US$19.6M | −25,600 | Jun 30, 2026 |
| Verastem, Inc. | 3.99M | US$15.2M | +1.85M | Jun 30, 2026 |
| X4 Pharmaceuticals, Inc. | 3.21M | US$15M | no change | Jun 30, 2026 |
| Eyepoint, Inc. | 988K | US$14.1M | −48,507 | Jun 30, 2026 |
| Cybin, Inc. | 1.96M | US$12.9M | +425K | Jun 30, 2026 |
| Vor Biopharma Inc. | 649K | US$11.9M | −51,400 | Jun 30, 2026 |
| Vaxcyte, Inc. | 200K | US$11.6M | −90,000 | Jun 30, 2026 |